Idiopathic Pulmonary Fibrosis Clinical Trials
Idiopathic Pulmonary Fibrosis clinical trials evaluate new inhaled and systemic therapies, devices, and management strategies for idiopathic Pulmonary Fibrosis. Corterve aggregates actively recruiting Idiopathic Pulmonary Fibrosis studies from ClinicalTrials.gov so you can search by location and eligibility. Respiratory trials often measure lung function and symptom control. This page is informational only and not medical advice; discuss participation with your healthcare provider.
Recruiting Idiopathic Pulmonary Fibrosis studies
- H01 in Adults With Interstitial Lung Disease (The SOLIS Study)NCT06325696PHASE2National Institute of Environmental Health Sciences (NIEHS)Research Triangle Park, North Carolina
- A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisNCT06968845PHASE2Rein TherapeuticsBirmingham, Alabama
- A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard TreatmentNCT07036523PHASE2Boehringer IngelheimBirmingham, Alabama
- Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)NCT05571059PHASE2Cumberland PharmaceuticalsLa Mesa, California
- Collection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesNCT01776398Weill Medical College of Cornell UniversityNew York, New York
- An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)NCT06951217PHASE2Avalyn Pharma Inc.Birmingham, Alabama
- A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastNCT06238622PHASE3Boehringer IngelheimBirmingham, Alabama
- Dose-Escalation Study of Artesunate Patients With IPFNCT05988463PHASE1Joseph C. WuStanford, California
- NAL ER IPF Respiratory Function and Safety StudyNCT07036029PHASE1Trevi TherapeuticsRochester, Minnesota
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)NCT00373841University of PittsburghPittsburgh, Pennsylvania
- The Genetics of Pulmonary FibrosisNCT03478553University of Colorado, DenverAurora, Colorado
- Interstitial Lung Disease Research Unit BiobankNCT05392881University of Kansas Medical CenterKansas City, Kansas
See all 26 recruiting Idiopathic Pulmonary Fibrosis trials →
Idiopathic Pulmonary Fibrosis trials by state
Idiopathic Pulmonary Fibrosis trials by metro
Frequently asked questions
- How do I find recruiting Idiopathic Pulmonary Fibrosis clinical trials?
- Corterve aggregates actively recruiting Idiopathic Pulmonary Fibrosis studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Idiopathic Pulmonary Fibrosis clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Idiopathic Pulmonary Fibrosis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.